Metformin could reduce long Covid rates, large study finds
Generic metformin could provide an affordable tool for preventing long Covid when taken at the time of Covid-19 infection.
FDA open for feedback on GCP draft guidance
FDA clears EpimAb’s IND for trial of cancer combo therapy
LianBio concludes subject enrolment in Phase III TP-03 trial in China
Oncternal doses first patient in trial of B cell lymphoma therapy
The challenges of clinical data management: Can consent management software help?
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan